DNA microarray analysis was used to investigate the molecular phenotype of one of the first human chondrocyte cell lines, C-20/A4, derived from juvenile costal chondrocytes by immortalization with origin-defective simian virus 40 large T antigen. Clontech Human Cancer Arrays 1.2 and quantitative PCR were used to examine gene expression profiles of C-20/A4 cells cultured in the presence of serum in monolayer and alginate beads. In monolayer cultures, genes involved in cell proliferation were strongly upregulated compared to those expressed by human adult articular chondrocytes in primary culture. Of the cell cycle-regulated genes, only two, the CDK regulatory subunit and histone H4, were downregulated after culture in alginate beads, consistent with the ability of these cells to proliferate in suspension culture. In contrast, the expression of several genes that are involved in pericellular matrix formation, including MMP-14, COL6A1, fibronectin, biglycan and decorin, was upregulated when the C-20/A4 cells were transferred to suspension culture in alginate. Also, nexin-1, vimentin, and IGFBP-3, which are known to be expressed by primary chondrocytes, were differentially expressed in our study. Consistent with the proliferative phenotype of this cell line, few genes involved in matrix synthesis and turnover were highly expressed in the presence of serum. These results indicate that immortalized chondrocyte cell lines, rather than substituting for primary chondrocytes, may serve as models for extending findings on chondrocyte function not achievable by the use of primary chondrocytes.

Keywords:
Alginate, Chondrocyte, Genomics, functional
1.
Adams, J.C., F.M. Watt (1993) Regulation of development and differentiation by the extracellular matrix. Development 117:1183–1198.
2.
Aigner, T., P.M. Gebhard, E. Schmid, B. Bau, V. Harley, E. Pöschl (2003) Sox 9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 22:363–372.
3.
Aigner, T., M. Hemmel, D. Neureiter, P.M. Gebhard, G. Zeiler, T. Kirchner, L.A. McKenna (2001) Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritic human articular knee cartilage: A study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum 44: 1304–1312.
4.
Aigner, T., H. Stöss, G. Weseloh, G. Zeiler, K. von der Mark (1992) Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 62: 337–345.
5.
Attur, M.G., M. Dave, C. Cipolletta, P. Kang, M.B. Goldring, I.R. Patel, S.B. Abramson, A.R. Amin (2000) Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J Biol Chem 275: 40307–40315.
6.
Attur, M.G., I.R. Patel, R.N. Patel, S.B. Abramson, A.R. Amin (1998) Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians 110: 65–72.
7.
Ayadi, A., M. Suelves, P. Dolle, B. Wasylyk (2001) Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mech Dev 102: 205–208.
8.
Bau, B., P.M. Gebhard, J. Haag, T. Knorr, E. Bartnik, T. Aigner (2002) Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46: 2648–2657.
9.
Benya, P.D., S.R. Padilla, M.E. Nimni (1978) Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 15: 1313–1321.
10.
Browning, J.A., R.J. Wilkins (2002) The effect of intracellular alkalinisation on intracellular Ca (2+) homeostasis in a human chondrocyte cell line. Pflügers Arch 444: 744–751.
11.
Catterall, J.B., S. Carrere, P.J. Koshy, B.A. Degnan, W.D. Shingleton, C.E. Brinckerhoff, J. Rutter, T.E. Cawston, A.D. Rowan (2001) Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 44: 2296–2310.
12.
Chubinskaya, S., K. Huch, M. Schulze, L. Otten, M.B. Aydelotte, A.A. Cole (2001) Gene expression by human articular chondrocytes cultured in alginate beads. J Histochem Cytochem 49:1211–1220.
13.
Coates, P.J., S.A. Hales, P.A. Hall (1996) The association between cell proliferation and apoptosis: Studies using the cell cycle-associated proteins Ki67 and DNA polymerase alpha. J Pathol 178: 71–77.
14.
de Crombrugghe, B., G. Zhou, V. Lefebvre, Z. Zhang, H. Eberspaecher (1998) Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273: 14989–14997.
15.
Farrell, D.H., S.L. Wagner, R.H. Yuan, D.D. Cunningham (1988) Localization of protease nexin-1 on the fibroblast extracellular matrix. J Cell Physiol 134: 179–188.
16.
Finger, F., C.M. Schörle, A. Zien, P.M. Gebhard, M.B. Goldring, T. Aigner (2003) Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, C-28/I2. Arthritis Rheum 48: 3395–3403.
17.
Gebhard, P.M., A. Gehrsitz, B. Bau, S. Söder, W. Eger, T. Aigner (2003) Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes. J Orthop Res 21: 96–101.
18.
Goldring, M.B. (2000) Osteoarthritis and cartilage: The role of cytokines. Curr Rheumatol Rep 2:459–465.
19.
Goldring, M.B., F. Berenbaum (1999) Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen expression. Osteoarthritis Cartilage 7: 386–388.
20.
Goldring, M.B., J.R. Birkhead, L.-F. Suen, R. Yamin, S. Mizuno, J. Glowacki, J.L. Arbiser, J.F. Apperley (1994) Interleukin-1-modulated gene expression in immortalized human chondrocytes. J Clin Invest 94: 2307–2316.
21.
Hambach, L., D. Neureiter, G. Zeiler, T. Kirchner, T. Aigner (1998) Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum 41: 986–996.
22.
Häuselmann, H.J., M.B. Aydelotte, B.L. Schumacher, K.E. Kuettner, S.H. Gitelis, E.J.M.A. Thonar (1992) Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. Matrix 12: 116–129.
23.
Häuselmann, H.J., R.J. Fernandes, S.S. Mok, T.M. Schmid, J.A. Block, M.B. Aydelotte, K.E. Kuettner, E.J.M.A. Thonar (1994) Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J Cell Sci 107: 17–27.
24.
Holtzer, H., J. Abbott, J.W. Lash, S. Holtzer (1960) The loss of phenotypic traits by differentiated cells in vitro. I. Dedifferentiation of cartilage cells. Proc Natl Acad Sci USA 46: 1533–1542.
25.
Im, H.J., C. Pacione, S. Chubinskaya, A.J. Van Wijnen, Y. Sun, R.F. Loeser (2003) Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 278: 25386–25394.
26.
Islam, S., T. Kermode, D. Sultana, R.W. Moskowitz, H. Mukhtar, C.J. Malemud, V.M. Goldberg, T.M. Haqqi (2001) Expression profile of protein tyrosine kinase genes in human osteoarthritis chondrocytes. Osteoarthritis Cartilage 9: 684–693.
27.
Johnson, K., S. Vaingankar, Y. Chen, A. Moffa, M.B. Goldring, K. Sano, P. Jin-Hua, A. Sali, J. Goding, R. Terkeltaub (1999) Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum 42: 1986–1997.
28.
Kandel, R.A., M. Petelycky, C.A. Dinarello, M. Minden, K.P.H. Pritzker, T.F. Cruz (1990) Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes. J Rheumatol 17:953–957.
29.
Kiepe, D., T. Ulinski, D.R. Powell, S.K. Durham, O. Mehls, B. Tonshoff (2002) Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int 62: 1591–1600.
30.
Kokenyesi, R., L. Tan, J.R. Robbins, M.B. Goldring (2000) Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys 383: 79–90.
31.
Kolettas, E., L. Buluwela, M.T. Bayliss, H.I. Muir (1995) Expression of cartilage-specific molecules is retained on long-term culture of human articular chondrocytes. J Cell Sci 108: 1991–1999.
32.
Koshy, P.J.T., C.J. Lundy, A.D. Rowan, S. Porter, D.R. Edwards, A. Hogan, I.M. Clark, T.E. Cawston (2002) The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M. Arthritis Rheum 46: 961–967.
33.
Labelle, Y., J. Bussieres, F. Courjal, M.B. Goldring (1999) The EWS/TEC fusion protein encoded by the t (9;22) chromosomal translocation in human chondrosarcomas is highly potent transcriptional activator. Oncogene 18: 3303–3308.
34.
Laflamme, C., C. Filion, J.A. Bridge, M. Ladanyi, M.B. Goldring, Y. Labelle (2003) The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer Res 63: 449–454.
35.
Lee, H.S., S.J. Millward-Sadler, M.O. Wright, G. Nuki, D.M. Salter (2000) Integrin and mechanosensitive ion channel-dependent tyrosine phosphorylation of focal adhesion proteins and beta-catenin in human articular chondrocytes after mechanical stimulation. J Bone Miner Res 15: 1501–1509.
36.
Lemare, F., N. Steimberg, C. Le Griel, S. Demignot, M. Adolphe (1998) Dedifferentiated chondrocytes cultured in alginate beads: Restoration of the differentiated phenotype and of the metabolic responses to interleukin-1beta. J Cell Physiol 176: 303–313.
37.
Loeser, R.F., C.B. Forsyth, A.M. Samarel, H.J. Im (2003) Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 278:24577–24585.
38.
Loeser, R.F., S. Sadiev, L. Tan, M.B. Goldring (2000) Integrin expression by primary and immortalized human chondrocytes: Evidence of a differential role for α1β1 and α2β1 integrins in mediating chondrocyte adhesion to types II and VI collagen. Osteoarthritis Cartilage 8: 96–105.
39.
Matsumoto, T., T. Tsurumoto, M.B. Goldring, H. Shindo (2000) Differential effects of IGF-binding proteins, IGFBP-3 and IGFBP-5, on IGF-I action and binding to cell membranes of immortalized human chondrocytes. J Endocrinol 166: 29–37.
40.
Mitchell, P.G., H.A. Magna, L.M. Reeves, L.L. Lopresti-Morrow, S.A. Yocum, P.J. Rosner, K.F. Geoghegan, J.E. Hambor (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97: 761–768.
41.
Mobasheri, A., G. Neama, S. Bell, S. Richardson, S.D. Carter (2002) Human articular chondrocytes express three facilitative glucose transporter isoforms: glut1, glut3 and glut9. Cell Biol Int 26: 297–300.
42.
Moulton, P.J., M.B. Goldring, J.T. Hancock (1998) NAPDH oxidase of chondrocytes contains an isoform of the gp91phox subunit. Biochem J 329: 449–451.
43.
Moulton, P.J., T.S. Hiran, M.B. Goldring, J.T. Hancock (1997) Detection of protein and mRNA of various components of the NAPDH oxidase complex in an immortalized human chondrocyte line. Br J Rheumatol 36: 522–529.
44.
Nuttall, M.E., D.P. Nadeau, P.W. Fisher, F. Wang, P.M. Keller, W.E. DeWolf, Jr., M.B. Goldring, A.M. Badger, D. Lee, M.A. Levy, M. Gowen, M.W. Lark (2000) Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. J Orthop Res 18: 356–363.
45.
Osaki, M., L. Tan, B.K. Choy, Y. Yoshida, K.S. Cheah, P.E. Auron, M.B. Goldring (2003) The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: Requirement for Stat1 alpha, Jak1 and Jak2. Biochem J 369: 103–115.
46.
Palmer, G., P.A. Guerne, F. Mezin, M. Maret, J. Guicheux, M.B. Goldring, C. Gabay (2002) Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res 4: 226–231.
47.
Pufe, T., V. Harde, W. Petersen, M.B. Goldring, B. Tillmann, R. Mentlein (2004) Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 202: 367–374.
48.
Richardson, S., G. Neama, T. Phillips, S. Bell, S.D. Carter, K.H. Moley, J.F. Moley, S.J. Vannucci, A. Mobasheri (2003) Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation. Osteoarthritis Cartilage 11: 92–101.
49.
Sironen, R., M. Elo, K. Kaarniranta, H.J. Helminen, M.J. Lammi (2000) Transcriptional activation in chondrocytes submitted to hydrostatic pressure. Biorheology 37: 85–93.
50.
Stephenson, M.L., M.B. Goldring, J.R. Birkhead, M. Krane, H.J. Rahmsdorf, P. Angel (1987) Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1β or phorbol ester. Biochem Biophys Res Commun 144: 583–590.
51.
Stokes, D.G., G. Liu, I.B. Coimbra, S. Velazquez, R.M. Crowl, S.A. Jimenez (2002) Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 46:404–419.
52.
Swietach, P., J.A. Browning, R.J. Wilkins (2002) Functional and molecular determination of carbonic anhydrase levels in bovine and cultured human chondrocytes. Comp Biochem Physiol B Biochem Mol Biol 133: 427–435.
53.
Tan, L., H. Peng, M. Osaki, B.K. Choy, P.E. Auron, L.J. Sandell, M.B. Goldring (2003) Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 278: 17688–17700.
54.
Van Osch, J.V.M., W.B. van den Berg, E.B. Hunziker, H.J. Häuselmann (1998) Differential effects of IGF-1 and TGFβ-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes. Osteoarthritis Cartilage 6: 187–195.
55.
Vetter, U., J. Zapf, W. Heit, G. Helbing, E. Heinze, E.R. Froesch, W.M. Teller (1986) Human fetal and adult chondrocytes – Effect of insulin-like growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest 77: 1903–1906.
56.
von der Mark, K., V. Gauss, H. von der Mark, P.K. Müller (1977) Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture. Nature 267: 531–532.
57.
Wachsmuth, L., B. Bau, Z. Fan, A. Pecht, N. Gerwin, T. Aigner (2004) ADAMTS-1, a gene product of articular chondrocytes in vivo and in vitro, is down-regulated by Il-1beta. J Rheumatol 31: 315–320.
58.
Zien, A., T. Aigner, R. Zimmer, T. Lengauer (2001) Centralization: A new method for the normalization of gene expression data. Bioinformatics 17: S323–S331.
59.
Zwicky, R., K. Muntener, M.B. Goldring, A. Baici (2002) Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes. Biochem J 367: 209–217.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.